Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Synapse. 2009 Apr;63(4):339–358. doi: 10.1002/syn.20611

Fig. 3.

Fig. 3

Graph of the time course of the percent of plasma radioactivity present as (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-[123I]IA) metabolites after the intravenous bolus administration of 9.3 mCi 5-[123I]IA to a 22-year-old male light smoker (Subject 3).